Elective Reversal (reversal needed within days)
- Low bleeding risk procedure
- Hold ≥24 hours
- High bleeding risk procedure
- Hold ≥48 hrs
Urgent Reversal (not bleeding, reversal needed within hours)
- Hold further doses
- Consider:
Urgent Reversal (bleeding, reversal needed immediately)
- HASHTI:
*The use of aPCC (FEIBA70) may be associated with a higher risk of thrombosis compared with nonactivated PCCs110
** Andexanet alfa (Andexxa) dosing:
- Rivaroxaban:
- ≤ 10 mg given in < 8 hrs or higher dose given ≥ 8 hrs: 400 mg IV bolus administered at a rate of ~30 mg/minute, followed 2 minutes later by 4 mg/minute IV infusion for up to 120 minutes
- > 10 mg given in < 8 hrs: 800 mg IV bolus administered at a rate of ~30 mg/minute, followed 2 minutes later by 8 mg/minute IV infusion for up to 120 minutes
